Nom du produit:1-Methyl-4-oxo-7-(trifluoromethyl)-4,5-dihydroimidazo[1,2-a]quinoxaline-2-carboxylic acid
IUPAC Name:1-methyl-4-oxo-7-(trifluoromethyl)-4H,5H-imidazo[1,2-a]quinoxaline-2-carboxylic acid
- CAS：164329-75-3
- Formule moléculaire：C13H8F3N3O3
- Pureté：97%
- Numéro de catalogue：CM222405
- Poids moléculaire：311.22
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:164329-75-3
- Formule moléculaire:C13H8F3N3O3
- Point de fusion:-
- Code SMILES:O=C(C1=C(C)N2C(C(NC3=C2C=CC(C(F)(F)F)=C3)=O)=N1)O
- Densité:
- Numéro de catalogue:CM222405
- Poids moléculaire:311.22
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.
- Imidazopyrazines
- In addition to the nitrogen-based heterocycles presented so far, a number of others nitrogen-based scaffolds have also been reported as promising agents for GBM treatment, including pyrazolo-triazole, imidazotetrazine, piperidine, purine, imidazopyrazine, pyrazole, triazole among others.
Recherche 
+86 21 5895 0110 
